[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100553405":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":24,"locations":34,"responsibleParty":52,"collaborators":10,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Ain Shams University","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Duchenne patients subjected to captopril",null,[12],"Drug: Captopril Tablets",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DRUG","Captopril Tablets","Patients will be given captopril to see effect on global longitudinal strain",[9],[20],{"name":21,"affiliation":22,"role":23},"Mona Mostafa Rayan, MD","Professor of cardiology -Ain Shams university","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Fatma Ebeid, MD","CONTACT","00201095569596","dr.fatma_ebeid@yahoo.com",{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},"Sandra M Mina","01060781869","sandramourad922@yahoo.com",[35],{"facility":36,"status":37,"city":38,"state":10,"zip":10,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Ain Shams university","RECRUITING","Cairo","Egypt","EG",{"type":42,"coordinates":43},"Point",[44,45],31.24967,30.06263,{"lat":45,"lon":44},[48,49,50],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},{"name":51,"role":23,"phone":10,"phoneExt":10,"email":10},"Mona M Rayan, MD",{"type":53,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100553405","early-phase-1-effect-of-captopril-on-gls-in-duchenne-myodystrophy-100553405",false,"NCT06485661","Effect of Captopril on GLS in Duchenne Myodystrophy","Intermediate Term Effect of Captopril on Left Ventricle Global Longitudinal Strain in Patients With Duchenne Myodystrophy","Inclusion Criteria:\n\n* Genetically confirmed Duchenne myodystrophy (DMD) patients with abnormal GLS \\\u003C -18% with minimum age of 6 years old.\n\nExclusion Criteria:\n\n* Any patient who refuses to sign an informed consent.\n* Contraindication to ACEI: hypersensitivity - renal impairment - bilateral renal artery stenosis - aortic valve stenosis - hyperkalemia - hypotension.\n* Reduced ejection fraction below 50%.","MALE","6 Years",{"count":64,"type":65},20,"ESTIMATED","INTERVENTIONAL",[68],"EARLY_PHASE1","To outline the intermediate term effect of prescribing Captopril as an add on therapy on Left ventricular functions as measured by Global longitudinal strain in patients with Duchenne myodystrophy (DMD)",[71],"Effect of Drug","2024-07-13",{"date":74,"type":75},"2024-07-16","ACTUAL",{"date":77,"type":75},"2024-01-01",{"date":79,"type":65},"2024-09-30",{"name":5,"class":6},1]